Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PTSD Coach as an early mobile intervention to improve cancer-related anxiety and psychosocial oncology uptake in patients newly diagnosed with head and neck cancer: pilot randomized controlled trial.
Ducharme L, Lo C, Hier M, Zeitouni A, Kost K, Mlynarek A, Antoni M, Kuhn E, Owen JE, Heyland D, Platt R, Fuehrmann F, Sadeghi N, Rosberger Z, Frenkiel S, Sultanem K, Shenouda G, Cury F, Henry M. Ducharme L, et al. Among authors: shenouda g. Pilot Feasibility Stud. 2024 Dec 21;10(1):153. doi: 10.1186/s40814-024-01556-7. Pilot Feasibility Stud. 2024. PMID: 39709459 Free PMC article.
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Cancer.
Sadeghi N, Subramaniam T, Richardson K, Mascarella M, Zeitouni A, Shenouda G, Sultanem K, Mlynarek A, Caglar D, Esfahani K, Joshi A, Siegel R, Goodman J, Thakkar P, Lee E, Golabi N, Ramanakumar AV, Hier M, Bouganim N. Sadeghi N, et al. Among authors: shenouda g. JAMA Otolaryngol Head Neck Surg. 2024 Dec 5:e243303. doi: 10.1001/jamaoto.2024.3303. Online ahead of print. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 39636629
Predicting short-term treatment toxicity in head and neck cancer through a systematic review and meta-analysis.
Mascarella MA, Vendra V, Sultanem K, Tsien C, Shenouda G, Sridharan S, Bouganim N, Esfahani K, Richardson K, Mlynarek A, Hier M, Sadeghi N, Duvvuri U, Kergoat MJ. Mascarella MA, et al. Among authors: shenouda g. J Geriatr Oncol. 2024 Nov;15(8):102064. doi: 10.1016/j.jgo.2024.102064. Epub 2024 Sep 13. J Geriatr Oncol. 2024. PMID: 39271411 Free article.
Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations.
Lim AM, McDowell L, Hurt C, Le Tourneau C, Homma A, Shenouda G, Thomson DJ, Moya-Plana A, Henson C, Szturz P, Day AT, Bates JE, Lazarakis S, Thariat J, Psyrri A, Mehanna H, Yom SS; HNCIG. Lim AM, et al. Among authors: shenouda g. Lancet Oncol. 2024 Jul;25(7):e318-e330. doi: 10.1016/S1470-2045(24)00067-6. Lancet Oncol. 2024. PMID: 38936390 Review.
Genetic Risk For Depression and Quality of Life in Patients With Head and Neck Cancer.
Henry M, Chen LM, Ducharme L, Devault-Tousignant C, Rosberger Z, Frenkiel S, Hier M, Zeitouni A, Kost K, Mlynarek A, Richardson K, Chartier G, Mascarella M, Sadeghi N, Sultanem K, Shenouda G, Cury FL, Meaney M. Henry M, et al. Among authors: shenouda g. JAMA Otolaryngol Head Neck Surg. 2024 Jul 1;150(7):598-606. doi: 10.1001/jamaoto.2024.0376. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38814668
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2405-2415. doi: 10.1016/S0140-6736(24)00548-8. Epub 2024 May 16. Lancet. 2024. PMID: 38763154 Free PMC article. Clinical Trial.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2416-2425. doi: 10.1016/S0140-6736(24)00549-X. Epub 2024 May 16. Lancet. 2024. PMID: 38763153 Free PMC article. Clinical Trial.
Sarcopenia predicts short-term treatment-related toxicity in patients undergoing curative-intent therapy for head and neck cancer: A systematic review and meta-analysis.
Mascarella MA, Ferdus J, Vendra V, Sridharan S, Sultanem K, Tsien C, Shenouda G, Bouganim N, Esfahani K, Richardson K, Mlynarek A, Sadeghi N, Hier M, Kergoat MJ. Mascarella MA, et al. Among authors: shenouda g. Head Neck. 2024 Jun;46(6):1500-1509. doi: 10.1002/hed.27688. Epub 2024 Feb 14. Head Neck. 2024. PMID: 38353170 Review.
Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma.
Faye MD, Easaw J, De Robles P, Agnihotram R, Torres-Vasquez A, Lamonde F, Petrecca K, Owen S, Panet-Raymond V, Shenouda G, Souhami L, Azam M, Hossain B, Alkass J, Sabri S, Abdulkarim B. Faye MD, et al. Among authors: shenouda g. Neurooncol Adv. 2023 Sep 12;5(1):vdad106. doi: 10.1093/noajnl/vdad106. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37771465 Free PMC article.
Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial.
Wong SJ, Torres-Saavedra PA, Saba NF, Shenouda G, Bumpous JM, Wallace RE, Chung CH, El-Naggar AK, Gwede CK, Burtness B, Tennant PA, Dunlap NE, Redman R, Stokes WA, Rudra S, Mell LK, Sacco AG, Spencer SA, Nabell L, Yao M, Cury FL, Mitchell DL, Jones CU, Firat S, Contessa JN, Galloway T, Currey A, Harris J, Curran WJ Jr, Le QT. Wong SJ, et al. Among authors: shenouda g. JAMA Oncol. 2023 Nov 1;9(11):1565-1573. doi: 10.1001/jamaoncol.2023.3809. JAMA Oncol. 2023. PMID: 37768670 Free PMC article. Clinical Trial.
116 results